Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Sutro Biopharma, Inc.”

34 pharma patents match "Sutro Biopharma, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 34
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 34 pharmaceutical patents matching "Sutro Biopharma, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

34 results for “Sutro Biopharma, Inc.” · 30,257 patents in full index Clear search

  1. US 12427201

    Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates

    Sutro Biopharma, Inc. · Granted Sep 30, 2025 · Expires Sep 25, 2045

    granted
  2. US 12398197

    Antibodies with engineered CH2 domains, compositions thereof and methods of using the same

    Sutro Biopharma, Inc. · Granted Aug 26, 2025 · Expires Aug 21, 2045

    granted
  3. US 12351850

    Methods of producing full-length antibodies using E. coli

    Sutro Biopharma, Inc. · Granted Jul 8, 2025 · Expires Jul 3, 2045

    granted
  4. US 12269801

    Modified amino acids

    Sutro Biopharma, Inc. · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted
  5. US 12252552

    Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use

    Sutro Biopharma, Inc. · Granted Mar 18, 2025 · Expires Mar 13, 2045

    granted
  6. US 12226490

    Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates preliminary class

    Sutro Biopharma, Inc. · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  7. US 12144869

    Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates

    Sutro Biopharma, Inc. · Granted Nov 19, 2024 · Expires Nov 14, 2044

    granted
  8. US 12071477

    Anti-folate receptor alpha antibody conjugated with hemiasterlins

    Sutro Biopharma, Inc. · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  9. US 11993658

    Anti-BCMA antibodies and treatment methods

    Sutro Biopharma, Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  10. US 11958909

    Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use

    Sutro Biopharma, Inc. · Granted Apr 16, 2024 · Expires Apr 11, 2044

    granted
  11. US 11866515

    Hemiasterlin derivatives for conjugation and therapy

    Sutro Biopharma, Inc. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  12. US 11744876

    Immunomodulator antibody drug conjugates and uses thereof

    Sutro Biopharma, Inc. · Granted Sep 5, 2023 · Expires Aug 31, 2043

    granted
  13. US 11708413

    Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugates

    Sutro Biopharma, Inc. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  14. US 11548852

    Modified amino acids

    Sutro Biopharma, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted
  15. US 11344626

    Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use

    Sutro Biopharma, Inc. · Granted May 31, 2022 · Expires May 26, 2042

    granted
  16. US 11098131

    Anti-EpCAM antibodies, compositions comprising anti-EpCAM antibodies and methods of making and using anti-EpCAM antibodies

    Sutro Biopharma, Inc. · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  17. US 11098107

    Antibodies with engineered CH2 domains, compositions thereof and methods of using the same

    Sutro Biopharma, Inc. · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  18. US 11014983

    Anti-Tim-3 antibodies, compositions comprising anti-Tim-3 antibodies and methods of making and using anti-Tim-3 antibodies

    Sutro Biopharma, Inc. · Granted May 25, 2021 · Expires May 20, 2041

    granted
  19. US 10975150

    Anti-CD74 antibodies, compositions comprising anti-CD74 antibodies and methods of using anti-CD74 antibodies

    Sutro Biopharma, Inc. · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted
  20. US 10844090

    Hemiasterlin derivatives for conjugation and therapy

    Sutro Biopharma, Inc. · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted
  21. US 10822414

    Anti-PD-1 antibodies, compositions comprising anti-PD-1 antibodies and methods of using anti-PD-1 antibodies

    Sutro Biopharma, Inc. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted
  22. US 10730837

    Modified amino acids

    Sutro Biopharma, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted
  23. US 10669347

    Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use

    Sutro Biopharma, Inc. · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  24. US 10596270

    Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates

    Sutro Biopharma, Inc. · Granted Mar 24, 2020 · Expires Mar 19, 2040

    granted